Skip to main content
Log in

Immediate and Long-term Neurocognitive Outcome in Patients with Obstructive Sleep Apnea Syndrome After Continuous Positive Airway Pressure Treatment

  • Original Article
  • Published:
Indian Journal of Otolaryngology and Head & Neck Surgery Aims and scope Submit manuscript

Abstract

Neurocognitive dysfunction is a major clinical consequence in patients with obstructive sleep apnea syndrome (OSAS). The effects of continuous positive airway pressure (CPAP) treatment, as the gold standard of treatment in OSAS, on this major complication are controversial. The duration and compliance of CPAP are thought to be important factors but evidence is lacking. This study is designed to evaluate the effects of immediate (one night), long-term (3 months) influence and the compliances of CPAP treatment on the neurocognitive function in OSAS patients. We enrolled newly diagnosed severe OSAS patients. Neurocognitive function test battery, CANTAB (Cambridge Neuropsychological Test Automated Battery), was performed before, one night and 3 months of CPAP treatment. Patients with CPAP compliance rate ≥ 70 % and < 50 % were grouped into good and poor adherence subjects, respectively. Fourteen patients were enrolled in final analyses. Six of them were in poor compliant group. Improvements in attention domain were found in all subjects after one-night treatment and maintained till three-month follow-up. Additional improvements in some attention performances and visual memory performances were gained only after three-month treatment. Significant changes of decision-making and response control function were found between good and poor compliance groups after three-month treatment. CPAP can improve some neurocognitive function at the very first day used. Longer treatment of CPAP can additionally improve some other neurocognitive functions. Compliance of CPAP has influence on the recovery of neurocognitive functions in patients with severe OSAS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S (1993) The occurrence of sleep-disordered breathing among middle-aged adults. New Engl J Med 328(17):1230–1235. doi:10.1056/NEJM199304293281704

    Article  CAS  PubMed  Google Scholar 

  2. Saunamaki T, Jehkonen M (2007) A review of executive functions in obstructive sleep apnea syndrome. Acta Neurol Scand 115(1):1–11. doi:10.1111/j.1600-0404.2006.00744.x

    Article  CAS  PubMed  Google Scholar 

  3. Sassani A, Findley LJ, Kryger M, Goldlust E, George C, Davidson TM (2004) Reducing motor-vehicle collisions, costs, and fatalities by treating obstructive sleep apnea syndrome. Sleep 27(3):453–458

    PubMed  Google Scholar 

  4. Engleman HM, Douglas NJ (2004) Sleep. 4: sleepiness, cognitive function, and quality of life in obstructive sleep apnoea/hypopnoea syndrome. Thorax 59(7):618–622

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  5. Bradley TD, Floras JS (2009) Obstructive sleep apnoea and its cardiovascular consequences. Lancet 373(9657):82–93. doi:10.1016/S0140-6736(08)61622-0

    Article  PubMed  Google Scholar 

  6. Phillips B, Kryger MH (2005) Management of obstructive sleep apnea syndrome: overview. In: Kryger MH, Roth T, Dement WC (eds) Principles and practice of sleep medicine. Elsevier Saunders, Philadelphia, pp 1109–1121

    Chapter  Google Scholar 

  7. Marin JM, Carrizo SJ, Vicente E, Agusti AG (2005) Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 365(9464):1046–1053. doi:10.1016/S0140-6736(05)71141-7

    Article  PubMed  Google Scholar 

  8. Weaver TE, Sawyer AM (2010) Adherence to continuous positive airway pressure treatment for obstructive sleep apnoea: implications for future interventions. Indian J Med Res 131:245–258

    PubMed Central  PubMed  Google Scholar 

  9. Sanchez AI, Martinez P, Miro E, Bardwell WA, Buela-Casal G (2009) CPAP and behavioral therapies in patients with obstructive sleep apnea: effects on daytime sleepiness, mood, and cognitive function. Sleep Med Rev 13(3):223–233. doi:10.1016/j.smrv.2008.07.002

    Article  PubMed  Google Scholar 

  10. Lojander J, Kajaste S, Maasilta P, Partinen M (1999) Cognitive function and treatment of obstructive sleep apnea syndrome. J Sleep Res 8(1):71–76

    Article  CAS  PubMed  Google Scholar 

  11. Henke KG, Grady JJ, Kuna ST (2001) Effect of nasal continuous positive airway pressure on neuropsychological function in sleep apnea-hypopnea syndrome. A randomized, placebo-controlled trial. Am J Respir Crit Care Med 163(4):911–917

    Article  CAS  PubMed  Google Scholar 

  12. Biegler KA, Chaoul MA, Cohen L (2009) Cancer, cognitive impairment, and meditation. Acta Oncol 48(1):18–26. doi:10.1080/02841860802415535

    Article  PubMed  Google Scholar 

  13. Zuccala G, Cattel C, Manes-Gravina E, Di Niro MG, Cocchi A, Bernabei R (1997) Left ventricular dysfunction: a clue to cognitive impairment in older patients with heart failure. J Neurol Neurosurg Psychiatry 63(4):509–512

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  14. Koushik NS, McArthur SF, Baird AD (2010) Adult chronic kidney disease: neurocognition in chronic renal failure. Neuropsychol Rev 20(1):33–51. doi:10.1007/s11065-009-9110-5

    Article  PubMed  Google Scholar 

  15. McAndrews MP, Farcnik K, Carlen P, Damyanovich A, Mrkonjic M, Jones S, Heathcote EJ (2005) Prevalence and significance of neurocognitive dysfunction in hepatitis C in the absence of correlated risk factors. Hepatology 41(4):801–808. doi:10.1002/hep.20635

    Article  PubMed  Google Scholar 

  16. Crews WD, Jefferson AL, Bolduc T, Elliott JB, Ferro NM, Broshek DK, Barth JT, Robbins MK (2001) Neuropsychological dysfunction in patients suffering from end-stage chronic obstructive pulmonary disease. Arch Clin Neuropsychol (the official journal of the National Academy of Neuropsychologists) 16(7):643–652

    Article  CAS  Google Scholar 

  17. Kadan-Lottick NS, Zeltzer LK, Liu Q, Yasui Y, Ellenberg L, Gioia G, Robison LL, Krull KR (2010) Neurocognitive functioning in adult survivors of childhood non-central nervous system cancers. J Nat Cancer Inst 102(12):881–893. doi:10.1093/jnci/djq156

    Article  PubMed Central  PubMed  Google Scholar 

  18. Conti F, Alessandri C, Perricone C, Scrivo R, Rezai S, Ceccarelli F, Spinelli FR, Ortona E, Marianetti M, Mina C, Valesini G (2012) Neurocognitive dysfunction in systemic lupus erythematosus: association with antiphospholipid antibodies, disease activity and chronic damage. PLoS ONE 7(3):e33824. doi:10.1371/journal.pone.0033824

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  19. Kushida CA, Littner MR, Morgenthaler T, Alessi CA, Bailey D, Coleman J Jr, Friedman L, Hirshkowitz M, Kapen S, Kramer M, Lee-Chiong T, Loube DL, Owens J, Pancer JP, Wise M (2005) Practice parameters for the indications for polysomnography and related procedures: an update for 2005. Sleep 28(4):499–521

    PubMed  Google Scholar 

  20. Chen NH, Johns MW, Li HY, Chu CC, Liang SC, Shu YH, Chuang ML, Wang PC (2002) Validation of a Chinese version of the Epworth sleepiness scale. Qual Life Res (an international journal of quality of life aspects of treatment, care and rehabilitation) 11(8):817–821

    Article  Google Scholar 

  21. De Luca CR, Wood SJ, Anderson V, Buchanan JA, Proffitt TM, Mahony K, Pantelis C (2003) Normative data from the CANTAB. I: development of executive function over the lifespan. J Clin Exp Neuropsychol 25(2):242–254. doi:10.1076/jcen.25.2.242.13639

    Article  PubMed  Google Scholar 

  22. Lange KW, Robbins TW, Marsden CD, James M, Owen AM, Paul GM (1992) L-dopa withdrawal in Parkinson’s disease selectively impairs cognitive performance in tests sensitive to frontal lobe dysfunction. Psychopharmacology 107(2–3):394–404

    Article  CAS  PubMed  Google Scholar 

  23. Sahakian BJ, Owen AM, Morant NJ, Eagger SA, Boddington S, Crayton L, Crockford HA, Crooks M, Hill K, Levy R (1993) Further analysis of the cognitive effects of tetrahydroaminoacridine (THA) in Alzheimer’s disease: assessment of attentional and mnemonic function using CANTAB. Psychopharmacology 110(4):395–401

    Article  CAS  PubMed  Google Scholar 

  24. Owen AM, Roberts AC, Polkey CE, Sahakian BJ, Robbins TW (1991) Extra-dimensional versus intra-dimensional set shifting performance following frontal lobe excisions, temporal lobe excisions or amygdalo-hippocampectomy in man. Neuropsychologia 29(10):993–1006

    Article  CAS  PubMed  Google Scholar 

  25. Lowe C, Rabbitt P (1998) Test/re-test reliability of the CANTAB and ISPOCD neuropsychological batteries: theoretical and practical issues. Cambridge neuropsychological test automated battery. International study of post-operative cognitive dysfunction. Neuropsychologia 36(9):915–923

    Article  CAS  PubMed  Google Scholar 

  26. Kribbs NB, Pack AI, Kline LR, Smith PL, Schwartz AR, Schubert NM, Redline S, Henry JN, Getsy JE, Dinges DF (1993) Objective measurement of patterns of nasal CPAP use by patients with obstructive sleep apnea. Am Rev Respir Dis 147(4):887–895

    Article  CAS  PubMed  Google Scholar 

  27. Orth M, Duchna HW, Leidag M, Widdig W, Rasche K, Bauer TT, Walther JW, de Zeeuw J, Malin JP, Schultze-Werninghaus G, Kotterba S (2005) Driving simulator and neuropsychological [corrected] testing in OSAS before and under CPAP therapy. Eur Respir J 26(5):898–903. doi:10.1183/09031936.05.00054704

    Article  CAS  PubMed  Google Scholar 

  28. Yang Q, Phillips CL, Melehan KL, Rogers NL, Seale JP, Grunstein RR (2006) Effects of short-term CPAP withdrawal on neurobehavioral performance in patients with obstructive sleep apnea. Sleep 29(4):545–552

    PubMed  Google Scholar 

  29. Antic NA, Catcheside P, Buchan C, Hensley M, Naughton MT, Rowland S, Williamson B, Windler S, McEvoy RD (2011) The effect of CPAP in normalizing daytime sleepiness, quality of life, and neurocognitive function in patients with moderate to severe OSA. Sleep 34(1):111–119

    PubMed Central  PubMed  Google Scholar 

  30. Monasterio C, Vidal S, Duran J, Ferrer M, Carmona C, Barbe F, Mayos M, Gonzalez-Mangado N, Juncadella M, Navarro A, Barreira R, Capote F, Mayoralas LR, Peces-Barba G, Alonso J, Montserrat JM (2001) Effectiveness of continuous positive airway pressure in mild sleep apnea-hypopnea syndrome. Am J Respir Crit Care Med 164(6):939–943

    Article  CAS  PubMed  Google Scholar 

  31. Engleman HM, Martin SE, Deary IJ, Douglas NJ (1997) Effect of CPAP therapy on daytime function in patients with mild sleep apnoea/hypopnoea syndrome. Thorax 52(2):114–119

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  32. Engleman HM, Kingshott RN, Wraith PK, Mackay TW, Deary IJ, Douglas NJ (1999) Randomized placebo-controlled crossover trial of continuous positive airway pressure for mild sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med 159(2):461–467

    Article  CAS  PubMed  Google Scholar 

  33. Engleman HM, Martin SE, Deary IJ, Douglas NJ (1994) Effect of continuous positive airway pressure treatment on daytime function in sleep apnoea/hypopnoea syndrome. Lancet 343(8897):572–575

    Article  CAS  PubMed  Google Scholar 

  34. Engleman HM, Martin SE, Kingshott RN, Mackay TW, Deary IJ, Douglas NJ (1998) Randomised placebo controlled trial of daytime function after continuous positive airway pressure (CPAP) therapy for the sleep apnoea/hypopnoea syndrome. Thorax 53(5):341–345

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  35. Weaver TE, Maislin G, Dinges DF, Bloxham T, George CF, Greenberg H, Kader G, Mahowald M, Younger J, Pack AI (2007) Relationship between hours of CPAP use and achieving normal levels of sleepiness and daily functioning. Sleep 30(6):711–719

    PubMed Central  PubMed  Google Scholar 

  36. Aloia MS, Ilniczky N, Di Dio P, Perlis ML, Greenblatt DW, Giles DE (2003) Neuropsychological changes and treatment compliance in older adults with sleep apnea. J Psychosom Res 54(1):71–76

    Article  PubMed  Google Scholar 

  37. Aloia MS, Di Dio L, Ilniczky N, Perlis ML, Greenblatt DW, Giles DE (2001) Improving compliance with nasal CPAP and vigilance in older adults with OAHS. Sleep Breath 5(1):13–21. doi:10.1007/s11325-001-0013-9

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This study is supported by the Chang Gung Medical Foundation, Grant number CMRPG 360501.

Conflict of Interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ning-Hung Chen.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOC 146 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lin, SW., Chou, YT., Kao, KC. et al. Immediate and Long-term Neurocognitive Outcome in Patients with Obstructive Sleep Apnea Syndrome After Continuous Positive Airway Pressure Treatment. Indian J Otolaryngol Head Neck Surg 67 (Suppl 1), 79–85 (2015). https://doi.org/10.1007/s12070-014-0777-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12070-014-0777-4

Keywords

Navigation